Jenburkt Pharmaceuticals announced a sharp rise in standalone net profit for the quarter ended June 2014. During the quarter, the profit of the company rose 59.00% to Rs 14.88 million from Rs 9.36 million in the same quarter previous year.
Net sales for the quarter rose 12.77% to Rs 192.26 million, compared with Rs 170 million for the prior year period.
Earnings per share for the quarter stood at Rs 3.20, registering 59.20% growth over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Jun - 14 | Jun - 13 | %Change |
| Net Sales | 192.27 | 170.49 | 12.77 |
| Net Profit | 14.88 | 9.36 | 59.00 |
| Basic EPS | 3.20 | 2.01 | 59.20 |
Shares of the company gained Rs 9.6, or 5.09%, to trade at Rs 198.15. The total volume of shares traded was 7,691 at the BSE (3.46 p.m., Monday).
